ENTITY
Intellia Therapeutics

Intellia Therapeutics (NTLA US)

15
Analysis
Health Care • United States
Intellia Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the research and clinical development of gene editing therapies for patients with genetically-based diseases.
more
Exchange Announcement • 09 Sep 2026 04:05

Current Report (Form 8-K | Period ending 2026-09-08)

Exchange Announcement • 05 Sep 2026 04:06

Current Report (Form 8-K | Period ending 2026-09-04)

Exchange Announcement • 07 Aug 2026 04:05

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 06 Aug 2026 19:45

Current Report (Form 8-K | Period ending 2026-08-06)

Exchange Announcement • 15 Jun 2026 20:52

Current Report (Form 8-K | Period ending 2026-06-13)

x